Oruka Therapeutics Inc (ORKA)

SG&A Expenses

$25.93M

TTM · Period ending: · USD

ORKA logo

ORKA SG&A Expenses

Latest reported$25.93M
ORKA TTM SG&A Expenses ($4.61M → $25.93M)
High-resolution chart · PNG

ORKA sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Oruka Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
25,933,000
23,468,000
21,383,000
20,622,544
19,263,544
17,741,544
14,250,544
9,768,000
7,595,000
6,465,000
6,172,000
5,940,000
5,555,000
5,270,000
4,963,000
5,386,000
5,437,000
5,273,000
5,412,000
5,607,000
5,269,000
4,940,000
4,681,000
3,645,000
3,610,000
3,744,000
3,892,000
3,919,000
3,957,000
3,908,000
3,856,999
4,416,999
4,480,999
4,527,999
4,609,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.